MichaelJohnHumphreyMD

PubMed

• 84 citations
  Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces.
  Joshua S. Boateng, Anthony D. Auffret, Kerr H. Matthews, Michael John Humphrey, Howard N.E. Stevens, G.M. Eccleston> ;International Journal of Pharmaceutics. 2010 Apr 15
• 5 citations
  A pharmacoscintigraphic study of three time-delayed capsule formulations in healthy male volunteers
  Jason T. McConville, Lee Ann Hodges, Tamara Jones, Janet Band, Bridget O'Mahony, Blythe Lindsay, Alistair Ross, Alastair J. Florence, Adrian J. Stanley, Michael John H...> ;Journal of Pharmaceutical Sciences. 2009 Nov 1
• 67 citations
  Development and mechanical characterization of solvent-cast polymeric films as potential drug delivery systems to mucosal surfaces
  Joshua S. Boateng, Howard N.E. Stevens, G.M. Eccleston, Anthony D. Auffret, Michael John Humphrey, Kerr H. Matthews> ;Drug Development and Industrial Pharmacy. 2009 Jul 28
• 29 citations
  Formulation, stability and thermal analysis of lyophilised wound healing wafers containing an insoluble MMP-3 inhibitor and a non-ionic surfactant
  Kerr H. Matthews, Howard N.E. Stevens, A.D. Auffret, Michael John Humphrey, G.M. Eccleston> ;International Journal of Pharmaceutics. 2008 May 22
• 11 citations
  In vivo performance of an oral MR matrix tablet formulation in the beagle dog in the fed and fasted state: assessment of mechanical weakness.
  Fiona J. McInnes, Nicola Clear, Michael John Humphrey, Howard N.E. Stevens> ;Pharmaceutical Research. 2008 May 1
• 11 citations
  Evaluation of the Clearance of a Sublingual Buprenorphine Spray in the Beagle Dog Using Gamma Scintigraphy
  Fiona J. McInnes, Nicola Clear, Gerry C James, Howard N.E. Stevens, Unai Vivanco, Michael John Humphrey> ;Pharmaceutical Research. 2008 Apr 1
• 10 citations
  Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-d...
  Andrew Collett, RH Stephens, Matthew D Harwood, Michael John Humphrey, Linda Dallman, Joanne Bennett, John D. Davis, Gordon L Carlson, Geoffrey Warhurst> ;Drug Metabolism and Disposition. 2008 Jan 1
• 27 citations
  Gamma-irradiation of lyophilised wound healing wafers.
  Kerr H. Matthews, Howard N.E. Stevens, A.D. Auffret, Michael John Humphrey, G.M. Eccleston> ;International Journal of Pharmaceutics. 2006 Apr 26
• 60 citations
  Lyophilised wafers as a drug delivery system for wound healing containing methylcellulose as a viscosity modifier.
  Kerr H. Matthews, Howard N.E. Stevens, A.D. Auffret, Michael John Humphrey, G.M. Eccleston> ;International Journal of Pharmaceutics. 2005 Jan 31
• 36 citations
  Evaluation of Pulsincap to provide regional delivery of dofetilide to the human gI tract
  Howard N.E. Stevens, Clive G. Wilson, Peter G. Welling, Massoud Bakhshaee, Julie Stephanie Binns, Alan C. Perkins, Malcolm Frier, Elaine P. Blackshaw, Margaret W Frame...> ;International Journal of Pharmaceutics. 2002 Apr 2
• 30 citations
  Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon.
  Nicola Clear, Ashley Milton, Michael John Humphrey, Brian Henry, Maria Wulff, Don Nichols, R.J. Anziano, Ian R. Wilding> ;European Journal of Pharmaceutical Sciences. 2001 Jul 1
• Formation and pharmacokinetics of the active drug candoxatrilat in mouse, rat, rabbit, dog and man following administration of the prodrug candoxatril.
  Kaye B, Brearley CJ, Cussans NJ, Herron M, Humphrey MJ, Mollatt AR> ;Xenobiotica. 1997-10-01
• 5 citations
  Disposition of azole antifungal agents. II. Hepatic binding and clearance of dichlorophenyl-bis-triazolylpropanol (DTP) in the rat.
  Bomont Hl, Michael H. Tarbit, Michael John Humphrey, J B Houston> ;Pharmaceutical Research. 1994 Jul 1
• Importance of metabolic stability and hepatic distribution to the pharmacokinetic profile of amlodipine.
  Walker DK, Humphrey MJ, Smith DA> ;Xenobiotica. 1994-03-01
• Bioanalytical data in decision making: discovery and development.
  Smith DA, Beaumont K, Cussans NJ, Humphrey MJ, Jezequel SG, Rance DJ, Stopher DA, Walker DK> ;Xenobiotica. 1992-01-01
• Design of toxicokinetic studies.
  Smith DA, Humphrey MJ, Charuel C> ;Xenobiotica. 1990-11-01
• The pharmacokinetics and metabolism of idazoxan in the rat.
  Lewis CJ, Havler ME, Humphrey MJ, Lloyd-Jones JG, McCleavy MA, Muir NC, Waltham K> ;Xenobiotica. 1988-05-01
• Metabolism and kinetics of amlodipine in man.
  Beresford AP, McGibney D, Humphrey MJ, Macrae PV, Stopher DA> ;Xenobiotica. 1988-02-01
• The metabolism and pharmacokinetics of amlodipine in humans and animals.
  Stopher DA, Beresford AP, Macrae PV, Humphrey MJ> ;J. Cardiovasc. Pharmacol.. 1988-01-01
• 62 citations
  The systemic bioavailability of buprenorphine by various routes of administration
  David Brewster, Michael J. Humphrey, Michael A. Mcleavy> ;The Journal of Pharmacy and Pharmacology. 2011 Apr 12
• Biliary excretion, metabolism and enterohepatic circulation of buprenorphine.
  Brewster D, Humphrey MJ, McLeavy MA> ;Xenobiotica. 1981-03-01
• Biotransformation of tolmesoxide in animals and man.
  Greenslade D, Havler ME, Humphrey MJ, Jordan BJ, Lewis CJ, Rance MJ> ;Xenobiotica. 1981-02-01
• The availability of carfecillin and its phenol moiety in rat and dog.
  Humphrey MJ, Filer CW, Jeffery DJ, Langley PF, Wadds GA> ;Xenobiotica. 1980-10-01
• Species differences in the metabolism and excretion of fenclofenac.
  Greenslade D, Havler ME, Humphrey MJ, Jordan BJ, Rance MJ> ;Xenobiotica. 1980-10-01
• The metabolism of carfecillin in rat, dog and man.
  Filer CW, Humphrey MJ, Jeffery DJ, Jones KH, Langley PF> ;Xenobiotica. 1980-10-01
• Join now to see all